芪倍合剂对溃疡性结肠炎大鼠白细胞介素-8、肿瘤坏死因子-α的影响

[目的]建立溃疡性结肠炎（UC）大鼠模型,研究芪倍合剂对大鼠溃疡性结肠炎（UC）的治疗作用及对肿瘤坏死因子-α（TNF-α）、白细胞介素8（IL-8）产生和表达的影响。[方法]用三硝基苯磺酸（TNBS）法制备大鼠UC模型,采用酶联免疫吸附（ELISA）方法测定大鼠血清中TNFα、IL-8水平。[结果]芪倍合剂组和柳氮磺胺吡啶组TNF-α、IL-8明显低于模型组,有统计学意义（P〈0．01）。[结论]芪倍合剂可显著降低UC大鼠血清TNF-α、IL-8的水平,有治疗UC的前景。     

经内镜栓塞治疗胃底静脉曲张破裂出血150例

目的　探讨经内镜栓塞治疗胃底静脉曲张破裂出血的疗效。方法　对 1 5 0例胃底静脉曲张破裂患者 ,经内镜工作通道置入栓塞注射针 ,向曲张静脉内注入组织粘合剂 ,使血液与组织粘合剂接触而迅速发生聚合、硬化 ,堵塞出血的曲张静脉而止血。结果　 1 5 0例均 1次成功止血 ,均未发生中毒反应、大出血、食管狭窄等并发症 ,随访 5个月 ,仅 3例 (2 %)再出血。结论　栓塞治疗胃底静脉曲张破裂出血疗效好 ,组织毒性小 ,副作用少 ,并发症发生率低。     

Dalitong Granule(达立通颗粒)Combined with Electroacupuncture in the Treatment of Functional Dyspepsia:A Randomized Controlled Trial

Objective:To explore clinical short and long-term effect of combining Dalitong Granule(达立通颗料,DG) and electroacupuncture group(EA) in the treatment of functional dyspepsia.Methods:Totally 640 patients with confirmed functional dyspepsia were randomly divided into 4 groups using a randomized digital table:the DG group,the EA group,the combined group and the control group,160 cases in each group.The DG group was treated with 6 g DG 3 times daily;the EA group was treated with puncture of points Zusanli(ST36),Zhongwan(CV12),Neiguan(PC6),Taichong(LR3) and Gongsun(SP4) twice daily;the combined group with above-mentioned DG and EA;and the control group with 5 mg mosapride 3 times,20 mg pantoprazole and25 mg amitriptylines twice daily.The treatment course was 4 weeks for all groups.The symptom score,quality of life score by Short Form 36 Health Survey Questionnaires(SF-36),plasma motilin by radioimmunoassay,electrogastrographic frequencies by electrogastrogram(EGG) and gastric emptying by B-sonography were examined,and adverse reactions were observed before,at the end of treatment and 60 weeks post-treatment.Results:In the DG group 1 case dropped out for not taking medicine strictly and 1 case was lost to follow-up,while 1 case in the EA group and 2 cases in the combined therapy group were lost to follow-up.Compared with pre-treatment,quality of life score,plasma motilin,electrogastrographic frequencies and gastric emptying were all increased significantly,while symptom score was decreased significantly at the end of treatment in each group(P0.01);in the combined group quality of life score,plasma motilin,electrogastrographic frequencies and gastric emptying were all significantly higher than those in the other groups,while symptom score was significantly lower than in the other groups(P0.05).Compared with at the end of treatment,these indices changed insignificantly in the combined group and the EA group 60 weeks post-treatment(P0.05),but the 4increased indices were all decreased significantly,and symptom score was increased significantly in the DG and the control groups(P0.05).The short and long-term total effective rates in the combined group were all significantly higher than those in the other treatment groups(P0.05 or P0.01).No serious adverse reaction occurred in the four groups.Conclusion:Combined treatment of DG and EA could increase both plasma motilin and electrogastrographic frequencies,promote gastric emptying,alleviate the symptom of dyspepsia so as to increase quality of life,with better safety and long-term effect.     

念珠菌性食管炎76例临床分析

白色念珠菌是口腔中正常菌种,其生长受其他共生菌的制约.近年念珠菌性食管炎检出率较高,一般认为多在应用抗生素、激素状况下以及恶性肿瘤状况下发生.本文对我院2005年3月至2007年3月胃镜检查诊断的念珠菌性食管炎进行内镜及临床分析,现报道如下.     

胃癌患者血清血管内皮生长因子和转化生长因子β1表达的关系及其临床意义

目的探讨胃癌患者血清血管内皮生长因子（VEGF）和转化生长因子β1（TGF—β1）的表达及二者联合检测的临床意义。方法采用酶联免疫吸附试验法（ELISA）定量检测84例胃癌患者和40例健康人血清VEGF和TGF—β1水平,并分析其与临床病理因素之间的关系。结果胃癌患者血清VEGF和TGF—β1水平明显高于健康人血清水平[（392．33±118．54）pg／mlVS（139．64±72．31）pg／ml,t=12．4098,P〈0．01;（692．8±14.5）mg／LVS（62．3±6.5）mg／L,t=262．3721,P〈0．01],其水平与浸润深度、分化程度、有无转移、TNM分期有关（P〈0．01）,与性别、年龄、肿瘤大小无统计学意义（P〉0．05）,胃癌患者血清VEGF与TGF-β1水平呈显著正相关（r=0．475,P〈0．01）。结论血清VEGF和TGF-β1。水平与胃癌蛳曼润、转移密切相关,术前检测血清VEGF、TGF—β1水平对预测胃癌的侵袭和转移具有重要的临床意义。     

电针联合芪倍合剂治疗腹泻型肠易激综合征腹泻型的随机对照研究（英文）

目的:旨在探讨电针联合芪倍合剂治疗IBSD的短期和远期疗效。方法:2012年7月至2016年6月新乡医学院第一附属医院消化科门诊和住院的644例确诊为肠易激综合征的病人,采用随机方法分为4组:电针组、芪倍合剂组、联合治疗组及西药组,每组161例。电针组针刺足三里、肝俞、脾俞、太冲及脐中四边穴,每日1次,共4周;芪倍合剂组予芪倍合剂50 mL口服,每日2次;联合治疗组则予上述电针针刺及芪倍合剂治疗;西药组口服复方地芬诺酯1片,每日2次,蒙脱石散3 g,每日3次,阿米替林25 mg,每日两次。评价4组患者治疗前、治疗结束时及治疗结束后60周排便次数、大便性状、伴随症状评分、生活质量评分及不良反应。结果:与治疗前比较,治疗结束时各组排便次数、大便性状和伴随症状评分均明显下降(P0.01),生活质量评分明显上升(P0.01),联合治疗组上述指标优于其他组(均P0.05)。与治疗结束时比较,治疗后6周上述指标在电针组和联合治疗组无明显反复(P0.05),在芪倍合剂组和对照组则明显反复(均P0.05),联合治疗组短期和远期总有效率均显著高于其他组的总有效率(P0.05,P0.01),各组均无严重不良反应发生。结论:电针和芪倍合剂均能显著减少IBSD患者排便次数,改善大便性状,缓解伴随症状,提高生活质量,但联合使用效果更好,并具有较好的安全性和近远期疗效。     

复方甘草酸苷注射液治疗溃疡性结肠炎疗效观察

目的 :观察复方甘草酸苷治疗溃疡性结肠炎的疗效。方法 :165例溃疡性结肠炎患者随机分为治疗组和对照组 ,分别给予复方甘草酸苷和柳氮磺胺吡啶治疗 ,比较两组的临床疗效。结果 :总有效率治疗组为92 38 % ,对照组为65 % (P<0 05) ;临床治愈率治疗组为63 80 % ,对照组为13 33 % (P<0 01)。结论:复方甘草酸苷治疗溃疡性结肠炎疗效显著     

饮酒和CYP1A1-MspI、ALDH-2基因多态性与食管癌的相关性

目的 探讨饮酒和细胞色素P4501A1-MspI (CYP1A1-MspI)、乙醛脱氢酶-2(ALDH-2)基因多态性与食管癌发病之间的关系.方法 采用病例-对照研究的方法,以160例食管癌患者及160例非癌对照者的外周血白细胞为样本,利用聚合酶链反应(PCR)技术分析了CYP1A1-MspI和ALDH-2基因多态性.结果 CYP1A1-MspI突变纯合型(m2/m2)和ALDH-2变异基因型频率分布分别为39.375%、70.625%(病例组)和20.000%、43.750% (对照组),二者差异显著(P<0.01,P<0.01).CYP1A1-MspI(m2/m2)患食管癌的风险显著增加(OR=2.598,95% CI=1.819~4.265).ALDH-2变异基因型者患食管癌的风险也显著增加(OR=3.091,95% CI=1.922~4.738).基因突变的协同分析发现CYP1A1-MspI(m2/m2)/ALDH-2变异基因型者在食管癌组和对照组中的分布频率分别为31.875%和6.250%,二者有显著差异(P<0.01).CYP1A1-MspI(m2/m2)/ALDH-2变异基因型者患食管癌的风险显著增加(OR=9.909,95% CI= 3.574~12.532).病例组的饮酒率显著高于对照组的饮酒率(OR=3.096,95% CI=1.532~4.88 0,P<0.01),CYP1A1-MspI (m2/m2)/及ALDH-2变异基因型与饮酒有协同作用(OR=40.727,95% CI=17.965~66.572).结论 CYP1A1-MspI(m2/m2)/ALDH-2变异基因型和饮酒是食管癌的易患因素,三者的联合在食管癌的发生中起着协同的作用.     

针灸治疗功能性便秘有效性及安全性研究

目的:探讨针灸治疗功能性便秘的临床疗效及其安全性.方法:将120例功能性便秘患者随机分为观察组和对照组,每组60例.观察组针刺天枢、上巨虚、足三里、大肠俞等穴;对照组则口服聚乙二醇4000和莫沙必利.观察两组患者治疗前、治疗后及治疗后4周随访排便次数、大便性状、排便困难症状评分、伴随症状评分、胃肠传输时间及不良反应.结果:与治疗前比较,两组治疗后排便次数明显增加,大便性状评分、排便困难症状评分、伴随症状评分、胃肠传输时间均明显下降(均P<0.01),治疗后两组间上述指标比较差异无统计学意义(均P>0.05);随访与治疗后比较,观察组上述指标无明显反复(均P>0.05),对照组则疗效不稳定,有所下降(均P<0.05),两组均无严重不良反应发生.结论:针灸能显著增加功能性便秘患者的排便次数、改变大便性状、缓解排便困难症状及伴随症状、缩短胃肠传输时间,并具有较好的安全性和耐受性,而且较口服聚乙二醇4000和莫沙必利疗效稳定.

Abstract：

Objective To explore clinical efficacy and safety of acupuncture in treatment of functional constipation. Methods One hundred and twenty cases were randomly divided into an observation group and a control group,60 cases in each group. The patients in the observation group were treated with acupuncture at Tiānshū(天枢 ST 25),Shàngjùxū(上巨虚 ST 37),Zúsānlǐ(足三里 ST 36),Dàchángshū(大肠俞 BL 25),etc.,and the control group was treated with oral administration of Macrogol 4000 and Mosapride. Defecation frequency,stool property,constipation symptom score,accompanying symptom score,gastrointestinal transit time and adverse reaction were observed before treatment,at the end of treatment and 4 weeks after treatment in the two groups. Results Compared with those before treatment,defecation frequency was increased significantly at the end of treatment in the two groups,while stool property,constipation symptom score,accompanying syndrome score and gastrointestinal transit time all were decreased significantly(all P<0.01),with no significant difference in these indexes between the two groups at the end of treatment (all P>0.05). Compared with the end of treatment,the above-mentioned indexes did not significantly recur in the observation group 4 weeks after the treatment (all P>0.05),but the therapeutic effects were unstable with decreased to some extent in the control group (all P<0.05). No serious adverse reaction was found in the two groups. Conclusion In the patients with functional constipation,acupuncture can significantly increase defecation frequency,change stool property,alleviate constipation and accompanying symptoms,and shorten gastrointestinal transit time with better safety and tolerance,and the therapeutic effect is more stable than that of Macrogol 4000 and Mosapride.     

扶正理气合剂对实验性功能性消化不良大鼠胃排空和胃动素的影响

目的:研究扶正理气合剂对大鼠功能性消化不良的治疗作用及其可能机制.方法:健康成年SD大鼠40只,随机分为空白对照组、模型组、莫沙必利组和扶正理气合剂,测定各组大鼠胃排空和血浆胃动素的含量.结果:模型组大鼠胃排空和血浆胃动素的含量明显低于空白对照组(25.85%±1.76%vs39.37%±2.18%,P＜0.05:129.38±22.27 mg/Lvs180.57±24.13 mg/L,P＜O.05).经治疗后,莫沙必利组和扶正理气合剂组明显升高,与模型组比较差异有统计学意义(37.37%±3.14%,38.19%±4.6l%vs 25.85%±1.76%,P＜0.05:210.51±42.59,227.36±40.74 mg/Lvs 129.38±22.27 mg/L,P＜0.05),而莫沙必利组和扶正理气合剂组之间差异无统计学意义.结论:扶正理气合剂能通过升高血浆中胃动素的含量而促进胃排空,这可能是该方治疗功能性消化不良作用机制之一.